Keyphrases
Critically Ill Patients
100%
Enoxaparin
100%
Anti-Xa
100%
Patient with Trauma
100%
Anti-Xa Level
100%
Dose Adjustment
37%
Hospital Discharge
25%
Venous Thromboembolism
25%
Injured Patients
25%
Venous Thromboembolic Events
25%
Sub-target
25%
High Dose
12%
Prospective Observational Study
12%
Standard of Care
12%
Major Bleeding
12%
Consecutive Patients
12%
In(III)
12%
Starting Dose
12%
One Dose
12%
Intensive Care Unit Length of Stay
12%
Performance Improvement
12%
Hospital Care
12%
Pharmacy
12%
Pharmacological Therapy
12%
Dose Titration
12%
Weight-based
12%
Penetrating Injury
12%
Bleeding Events
12%
Improvement Initiatives
12%
Trauma Intensive Care Unit
12%
Venous Bleeding
12%
Anti-Xa Monitoring
12%
New Weights
12%
Pharmacology, Toxicology and Pharmaceutical Science
Injury
100%
Enoxaparin
100%
Venous Thromboembolism
57%
Bleeding
14%
Observational Study
14%
Penetrating Trauma
14%